tolmetin has been researched along with Syndrome in 2 studies
Tolmetin: A non-steroidal anti-inflammatory agent (ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL) similar in mode of action to INDOMETHACIN.
tolmetin : A monocarboxylic acid that is (1-methylpyrrol-2-yl)acetic acid substituted at position 5 on the pyrrole ring by a 4-methylbenzoyl group. Used in the form of its sodium salt dihydrate as a nonselective nonsteroidal anti-inflammatory drug.
Syndrome: A characteristic symptom complex.
Excerpt | Relevance | Reference |
---|---|---|
" Ketorolac can be well tolerated in high-dose, long-term use even in this frail patient population." | 6.69 | The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: application in bone metastases and the opioid bowel syndrome. ( Joishy, SK; Walsh, D, 1998) |
" Ketorolac can be well tolerated in high-dose, long-term use even in this frail patient population." | 2.69 | The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: application in bone metastases and the opioid bowel syndrome. ( Joishy, SK; Walsh, D, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Joishy, SK | 1 |
Walsh, D | 1 |
Flannery, DB | 1 |
1 trial available for tolmetin and Syndrome
Article | Year |
---|---|
The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: application in bone metastases and the opioid bowel syndrome.
Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Bone Neoplasms; Colonic Ps | 1998 |
1 other study available for tolmetin and Syndrome
Article | Year |
---|---|
Syndrome of imperforate oropharynx with costovertebral and auricular anomalies.
Topics: Abnormalities, Drug-Induced; Amitriptyline; Ear, External; Female; Humans; Infant, Newborn; Infant, | 1989 |